Human CRMP4 mutation and disrupted Crmp4 expression in mice are associated with ASD characteristics and sexual dimorphism

[1]  P. Billuart,et al.  The X-Linked Intellectual Disability Protein IL1RAPL1 Regulates Dendrite Complexity , 2017, The Journal of Neuroscience.

[2]  Ning Cheng,et al.  Dendritic overgrowth and elevated ERK signaling during neonatal development in a mouse model of autism , 2017, PloS one.

[3]  Y. Goshima,et al.  Deletion of Crmp4 attenuates CSPG-induced inhibition of axonal growth and induces nociceptive recovery after spinal cord injury , 2016, Molecular and Cellular Neuroscience.

[4]  Sumei Li,et al.  CRMP4 regulates dendritic growth and maturation via the interaction with actin cytoskeleton in cultured hippocampal neurons , 2016, Brain Research Bulletin.

[5]  Y. Goshima,et al.  Deletion of collapsin response mediator protein 4 results in abnormal layer thickness and elongation of mitral cell apical dendrites in the neonatal olfactory bulb , 2016, Journal of anatomy.

[6]  Michael L. Gatza,et al.  Proteogenomics connects somatic mutations to signaling in breast cancer , 2016, Nature.

[7]  Maureen S. Durkin,et al.  Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012 , 2018, Morbidity and mortality weekly report. Surveillance summaries.

[8]  A. Nakae,et al.  Sensory cognitive abnormalities of pain in autism spectrum disorder: a case–control study , 2016, Annals of General Psychiatry.

[9]  D. Srivastava,et al.  Control of Dendritic Spine Morphological and Functional Plasticity by Small GTPases , 2016, Neural plasticity.

[10]  Y. Goshima,et al.  Mouse pups lacking collapsin response mediator protein 4 manifest impaired olfactory function and hyperactivity in the olfactory bulb , 2015, The European journal of neuroscience.

[11]  A. Hardan,et al.  Developing Medications Targeting Glutamatergic Dysfunction in Autism: Progress to Date , 2015, CNS Drugs.

[12]  Brian K. Lee,et al.  Changes in Prevalence of Autism Spectrum Disorders in 2001–2011: Findings from the Stockholm Youth Cohort , 2014, Journal of Autism and Developmental Disorders.

[13]  Tewarit Sarachana,et al.  Investigation of sex differences in the expression of RORA and its transcriptional targets in the brain as a potential contributor to the sex bias in autism , 2015, Molecular Autism.

[14]  Sumei Li,et al.  CRMP4 and CRMP2 Interact to Coordinate Cytoskeleton Dynamics, Regulating Growth Cone Development and Axon Elongation , 2015, Neural plasticity.

[15]  Margot J. Taylor,et al.  Decreased sensitivity to thermal stimuli in adolescents with autism spectrum disorder: relation to symptomatology and cognitive ability. , 2015, The journal of pain : official journal of the American Pain Society.

[16]  R. Gibbs,et al.  Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. , 2015, Human molecular genetics.

[17]  M. Wöhr.  Effect of social odor context on the emission of isolation-induced ultrasonic vocalizations in the BTBR T+tf/J mouse model for autism , 2015, Front. Neurosci..

[18]  N. Alenina,et al.  Reduced isolation-induced pup ultrasonic communication in mouse pups lacking brain serotonin , 2015, Molecular Autism.

[19]  Y. Goshima,et al.  Crmp4 deletion promotes recovery from spinal cord injury by neuroprotection and limited scar formation , 2015, Scientific Reports.

[20]  Boris Yamrom,et al.  The contribution of de novo coding mutations to autism spectrum disorder , 2014, Nature.

[21]  Kali T. Witherspoon,et al.  Recurrent de novo mutations implicate novel genes underlying simplex autism risk , 2014, Nature Communications.

[22]  Kathryn Roeder,et al.  De novo insertions and deletions of predominantly paternal origin are associated with autism spectrum disorder. , 2014, Cell reports.

[23]  J. Cloutier,et al.  Collapsin Response Mediator Protein 4 Regulates Growth Cone Dynamics through the Actin and Microtubule Cytoskeleton* , 2014, The Journal of Biological Chemistry.

[24]  Ryan M. Smith,et al.  Family‐Based Clinical Associations and Functional Characterization of the Serotonin 2A Receptor Gene (HTR2A) in Autism Spectrum Disorder , 2014, Autism research : official journal of the International Society for Autism Research.

[25]  K. Chadman,et al.  Mice over-expressing BDNF in forebrain neurons develop an altered behavioral phenotype with age , 2014, Behavioural Brain Research.

[26]  E. Hollander,et al.  The Role of Ionotropic Glutamate Receptors in Childhood Neurodevelopmental Disorders: Autism Spectrum Disorders and Fragile X Syndrome , 2014, Current neuropharmacology.

[27]  Fumio Nakamura,et al.  Amyloid-β25–35 induces impairment of cognitive function and long-term potentiation through phosphorylation of collapsin response mediator protein 2 , 2013, Neuroscience Research.

[28]  T. Baram,et al.  NMDA Receptor Activation and Calpain Contribute to Disruption of Dendritic Spines by the Stress Neuropeptide CRH , 2013, The Journal of Neuroscience.

[29]  S. Ogawa,et al.  Collapsin response mediator protein 4 affects the number of tyrosine hydroxylase‐immunoreactive neurons in the sexually dimorphic nucleus in female mice , 2013, Developmental neurobiology.

[30]  S. Wakana,et al.  ENU-mutagenesis mice with a non-synonymous mutation in Grin1 exhibit abnormal anxiety-like behaviors, impaired fear memory, and decreased acoustic startle response , 2013, BMC Research Notes.

[31]  N. Braidy,et al.  Excitotoxicity in the Pathogenesis of Autism , 2013, Neurotoxicity Research.

[32]  Jessica R. Jones,et al.  Changes in prevalence of parent-reported autism spectrum disorder in school-aged U.S. children: 2007 to 2011-2012. , 2013, National health statistics reports.

[33]  T. Abe,et al.  CRMP4 suppresses apical dendrite bifurcation of CA1 pyramidal neurons in the mouse hippocampus , 2012, Developmental neurobiology.

[34]  R. Ohtani-Kaneko,et al.  Postnatal alteration of collapsin response mediator protein 4 mRNA expression in the mouse brain , 2012, Journal of anatomy.

[35]  D. Pinto,et al.  SHANK1 Deletions in Males with Autism Spectrum Disorder. , 2012, American journal of human genetics.

[36]  Anne-Marie Le Sourd,et al.  Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2 , 2012, Nature.

[37]  Kenny Q. Ye,et al.  De Novo Gene Disruptions in Children on the Autistic Spectrum , 2012, Neuron.

[38]  Michael F. Walker,et al.  De novo mutations revealed by whole-exome sequencing are strongly associated with autism , 2012, Nature.

[39]  Evan T. Geller,et al.  Patterns and rates of exonic de novo mutations in autism spectrum disorders , 2012, Nature.

[40]  Jeremy Veenstra-VanderWeele,et al.  Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior , 2012, Proceedings of the National Academy of Sciences.

[41]  Bradley P. Coe,et al.  Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations , 2012, Nature.

[42]  M. Mizuguchi,et al.  Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex , 2012, Nature Communications.

[43]  Enrico Cherubini,et al.  Alterations of GABAergic Signaling in Autism Spectrum Disorders , 2011, Neural plasticity.

[44]  Jacqueline N. Crawley,et al.  Communication Impairments in Mice Lacking Shank1: Reduced Levels of Ultrasonic Vocalizations and Scent Marking Behavior , 2011, PloS one.

[45]  Rebecca C. Knickmeyer,et al.  Why Are Autism Spectrum Conditions More Prevalent in Males? , 2011, PLoS biology.

[46]  Serafim Batzoglou,et al.  Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP++ , 2010, PLoS Comput. Biol..

[47]  C. Lord,et al.  Behavioural phenotyping assays for mouse models of autism , 2010, Nature Reviews Neuroscience.

[48]  M. Pool,et al.  GSK3β Regulates Myelin-Dependent Axon Outgrowth Inhibition through CRMP4 , 2010, The Journal of Neuroscience.

[49]  Kendal Broadie,et al.  Genetic Controls Balancing Excitatory and Inhibitory Synaptogenesis in Neurodevelopmental Disorder Models , 2010, Front. Syn. Neurosci..

[50]  J. Rubenstein.  Three hypotheses for developmental defects that may underlie some forms of autism spectrum disorder , 2010, Current opinion in neurology.

[51]  Elena Patten,et al.  Sensory features and repetitive behaviors in children with autism and developmental delays , 2010, Autism research : official journal of the International Society for Autism Research.

[52]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[53]  Yuqing Li,et al.  A mental retardation gene, motopsin /neurotrypsin /prss12, modulates hippocampal function and social interaction , 2009, The European journal of neuroscience.

[54]  Sarah Curran,et al.  A Common Variant in DRD3 Receptor Is Associated with Autism Spectrum Disorder , 2009, Biological Psychiatry.

[55]  Maria Luisa Scattoni,et al.  Ultrasonic vocalizations: A tool for behavioural phenotyping of mouse models of neurodevelopmental disorders , 2009, Neuroscience & Biobehavioral Reviews.

[56]  A. Frick,et al.  Synaptic ionotropic glutamate receptors and plasticity are developmentally altered in the CA1 field of Fmr1 knockout mice , 2009, The Journal of physiology.

[57]  Angelica Ronald,et al.  The ‘Fractionable Autism Triad’: A Review of Evidence from Behavioural, Genetic, Cognitive and Neural Research , 2008, Neuropsychology Review.

[58]  V. Berezin,et al.  Signaling mechanisms of neurite outgrowth induced by the cell adhesion molecules NCAM and N-Cadherin , 2008, Cellular and Molecular Life Sciences.

[59]  B. Chakravarthy,et al.  Co-localization and interaction of DPYSL3 and GAP43 in primary cortical neurons. , 2007, Biochemical and biophysical research communications.

[60]  M. Pool,et al.  Identification of CRMP4 as a Convergent Regulator of Axon Outgrowth Inhibition , 2007, The Journal of Neuroscience.

[61]  S. Baader,et al.  Collapsin response mediator protein-4 regulates F-actin bundling. , 2005, Experimental cell research.

[62]  J. Vincent,et al.  Use of ultrasonic vocalizations to assess olfactory detection in mouse pups treated with 3-methylindole , 2005, Behavioural Processes.

[63]  B. Kieffer,et al.  Deficit in Attachment Behavior in Mice Lacking the µ-Opioid Receptor Gene , 2004, Science.

[64]  M. Spence,et al.  A case of autism with an interstitial deletion on 4q leading to hemizygosity for genes encoding for glutamine and glycine neurotransmitter receptor sub-units (AMPA 2, GLRA3, GLRB) and neuropeptide receptors NPY1R, NPY5R , 2004, BMC Medical Genetics.

[65]  E. Fombonne.  Epidemiological Surveys of Autism and Other Pervasive Developmental Disorders: An Update , 2003, Journal of autism and developmental disorders.

[66]  I. Pastan,et al.  Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[67]  C. Viebahn,et al.  Collapsin Response Mediator Proteins of Neonatal Rat Brain Interact with Chondroitin Sulfate* , 2003, The Journal of Biological Chemistry.

[68]  K. Kaibuchi,et al.  CRMP-2 binds to tubulin heterodimers to promote microtubule assembly , 2002, Nature Cell Biology.

[69]  J. Pevsner,et al.  Postmortem brain abnormalities of the glutamate neurotransmitter system in autism , 2001, Neurology.

[70]  K. Miczek,et al.  Distress vocalizations in maternally separated mouse pups: modulation via 5-HT1A, 5-HT1B and GABAA receptors , 2000, Psychopharmacology.

[71]  Chang Soon Choi,et al.  MeCP2 Modulates Sex Differences in the Postsynaptic Development of the Valproate Animal Model of Autism , 2014, Molecular Neurobiology.

[72]  俊成 木村（磯野）,et al.  Amyloid-β25-35 induces impairment of cognitive function and long-term potentiation through phosphorylation of collapsin response mediator protein 2 , 2014 .

[73]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[74]  L. Kanner.  Autistic disturbances of affective contact. , 1968, Acta paedopsychiatrica.